BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2835707)

  • 1. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins.
    Mancardi GL; Cadoni A; Zicca A; Schenone A; Tabaton M; De Martini I; Zaccheo D
    Neurology; 1988 Jun; 38(6):848-51. PubMed ID: 2835707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwann cell expression of HLA-DR antigen in peripheral neuropathies.
    Cadoni A; Zicca A; Mancardi GL
    Lancet; 1986 Nov; 2(8518):1281-2. PubMed ID: 2878162
    [No Abstract]   [Full Text] [Related]  

  • 3. Class II antigen expression in peripheral neuropathies.
    Mitchell GW; Williams GS; Bosch EP; Hart MN
    J Neurol Sci; 1991 Apr; 102(2):170-6. PubMed ID: 1649260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of class II molecules in normal and pathological nerves. Immunocytochemical studies in vivo and in tissue culture.
    Scarpini E; Lisak RP; Beretta S; Velicogna M; Doronzo R; Moggio M; Jann S; Scarlato G
    Brain; 1990 Jun; 113 ( Pt 3)():659-75. PubMed ID: 2163718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR expression in peripheral neuropathies: the role of Schwann cells, resident and hematogenous macrophages, and endoneurial fibroblasts.
    Sommer C; Schröder JM
    Acta Neuropathol; 1995; 89(1):63-71. PubMed ID: 7709733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy.
    Van Rhijn I; Van den Berg LH; Bosboom WM; Otten HG; Logtenberg T
    Brain; 2000 Oct; 123 ( Pt 10)():2020-9. PubMed ID: 11004119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunocompetence of Schwann cells.
    Meyer zu Hörste G; Hu W; Hartung HP; Lehmann HC; Kieseier BC
    Muscle Nerve; 2008 Jan; 37(1):3-13. PubMed ID: 17823955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Schwann cell and peripheral T-cell activation epitopes in hereditary motor and sensory neuropathy.
    Williams LL; Kissel JT; Shannon BT; Wright FS; Mendell JR
    J Neuroimmunol; 1992 Feb; 36(2-3):147-55. PubMed ID: 1370667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroinflammatory role of Schwann cells in disease.
    Ydens E; Lornet G; Smits V; Goethals S; Timmerman V; Janssens S
    Neurobiol Dis; 2013 Jul; 55():95-103. PubMed ID: 23523637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary sensory motor neuropathy: degenerative disease or a disease with an immune-mediated pathogenesis?].
    Cadoni A; Zicca A; Mancardi GL; De Martini I; Schenone A; Zaccheo D
    Boll Soc Ital Biol Sper; 1989 May; 65(5):399-404. PubMed ID: 2775546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.
    Mathey EK; Park SB; Hughes RA; Pollard JD; Armati PJ; Barnett MH; Taylor BV; Dyck PJ; Kiernan MC; Lin CS
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):973-85. PubMed ID: 25677463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae.
    Samuel NM; Mirsky R; Grange JM; Jessen KR
    Clin Exp Immunol; 1987 Jun; 68(3):500-9. PubMed ID: 3115648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR-expressing cells and T-lymphocytes in sural nerve biopsies.
    Schrøder HD; Olsson T; Solders G; Kristensson K; Link H
    Muscle Nerve; 1988 Aug; 11(8):864-70. PubMed ID: 3262825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.
    McDonald GB; Jewell DP
    J Clin Pathol; 1987 Mar; 40(3):312-7. PubMed ID: 3558865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localizations of class II antigens and nerve fibers in human carious teeth: HLA-DR immunoreactivity in Schwann cells.
    Yoshiba N; Yoshiba K; Iwaku M; Ozawa H
    Arch Histol Cytol; 1998 Oct; 61(4):343-52. PubMed ID: 9862149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR expression by adrenocortical cells of the zona reticularis: structural and allotypic characterization.
    Khoury EL; Berline JW
    Tissue Antigens; 1988 Apr; 31(4):191-203. PubMed ID: 3043760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of monoclonal antibodies directed against HLA class II molecules.
    Cabrera T; Ruiz-Cabello F; Lopez MA; de la Higuera B; Sanchez M; Garrido F
    Hybridoma; 1986; 5(3):191-7. PubMed ID: 3770773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy.
    Murata K; Dalakas MC
    Brain; 2000 Aug; 123 ( Pt 8)():1660-6. PubMed ID: 10908195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.